Drug intelligence / Profile preview

Anticancer medication

Development stage
Unknown
Modality
Cell Therapies, Alpha Emitters → Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gene Silencing → Gene Therapies, Beta Emitters → Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gene Editing → Gene Therapies, Gene Addition/Replacement → Gene Therapies, Small Molecules
Administration
Oral, Intravenous, Subcutaneous, Intramuscular, Topical
01

Overview

Anticancer medications, also known as antineoplastic agents, are a broad category of drugs used to treat cancer. These medications work through various mechanisms to target and destroy cancer cells, inhibit their growth, or prevent their spread. They can include traditional chemotherapy agents that directly damage DNA or interfere with cell division, targeted therapies that block specific molecular pathways involved in cancer growth, immunotherapies that harness the body's immune system to fight cancer, and hormonal therapies that block hormone production or action in hormone-sensitive cancers. The choice of medication depends on the type of cancer, its stage, and the patient's overall health.

02

Targets

TOP1 (DNA Topoisomerase I)DNATOP2A (DNA topoisomerase II)

Beyond the preview

Go deeper on Anticancer medication.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anticancer medication.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call